GlassScriptPhysician profile
Andrew D Kersten
NPI 1699975474
$41,107.40
in general payments reported to CMS, 2019-2025
25 companies · $3,270 in 2025
The $3,270 reported for 2025 was more than what 76% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,982 · 2020: $4,197 · 2021: $5,715 · 2022: $2,608 · 2023: $8,006 · 2024: $13K · 2025: $3,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,356 · Consulting Fee: $8,614 · Travel and Lodging: $3,436 · Food and Beverage: $3,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,356.33 |
| Consulting Fee | $8,614.00 |
| Travel and Lodging | $3,436.26 |
| Food and Beverage | $3,200.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $32,794.10 | 2019-2025 | Arthrex, Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems |
| Peerless Surgical INC. | $6,615.32 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $438.86 | 2019-2023 | Persona, Tricera Handpiece |
| Stryker Corporation | $210.39 | 2022-2025 | Clottriever Bold Catheter, Mako, Variax |
| Depuy Synthes Sales INC. | $181.88 | 2020-2025 | Attune |
| Vertex Pharmaceuticals Incorporated | $101.58 | 2025 | |
| Smith+Nephew, INC. | $99.00 | 2019 | |
| Inari Medical, INC. | $94.15 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Orthofix Medical, INC. | $87.65 | 2022-2025 | Cervical-Stim |
| Onkos Surgical, INC. | $87.14 | 2024 | Eleos Limb Salvage System |
| Bioventus LLC | $63.00 | 2021-2023 | Durolane |
| Medacta USA, INC. | $48.48 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $41.77 | 2023-2024 | Exparel, Zilretta, Iovera |
| Ferring Pharmaceuticals INC. | $38.40 | 2021-2022 | |
| Medtronic, INC. | $25.31 | 2025 | Mastergraft Matrix Ext |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $24.60 | 2019 | |
| Vericel Corporation | $21.39 | 2025 | |
| Abbott Laboratories | $20.33 | 2024 | Penta |
| Curonix LLC | $19.05 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $18.44 | 2023 | Prolia, Evenity |
| Nevro Corp. | $18.44 | 2024 | Senza |
| Axonics, INC. | $17.08 | 2023 | Axonics |
| Merz Pharmaceuticals, LLC | $15.91 | 2024 | Xeomin |
| Heron Therapeutics, INC. | $14.22 | 2023 | Zynrelef |
| Djo, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kersten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.